Elias Papatheodorou
Amministratore Delegato presso Calliditas Therapeutics Suisse SA
Provenienza dei contatti di primo grado di Elias Papatheodorou
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.
9
| Subsidiary | Pharmaceuticals: Generic | 9 |
HepaRegeniX GmbH
 HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany.
9
| Holding Company | Miscellaneous Commercial Services | 9 |
| Subsidiary | Pharmaceuticals: Major | 8 | |
Tribune Therapeutics AB
 Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Memo Therapeutics AG
 Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland.
5
| Holding Company | Biotechnology | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Elias Papatheodorou tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| IPSEN | Pharmaceuticals: Major | Corporate Officer/Principal | |
| KINDRED BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Founder Private Equity Analyst Private Equity Investor | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
Locanis AG
 Locanis AG Air Freight/CouriersTransportation LOCANIS AG specializes in the process optimization and goods tracking in warehouse logistics. Its products are site optimizer G40, G60, and GFLEX. In addition the firm offers mobile unit optimizers. The company was founded in 1985 and is headquartered in Unterföhring, Germany. | Air Freight/Couriers | Director/Board Member | |
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
| Stockholm School of Economics | College/University | Undergraduate Degree Masters Business Admin | |
| SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member Director/Board Member | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| University of Lausanne | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| Sciences Po | College/University | Undergraduate Degree | |
| HELIAD AG | Investment Managers | Chief Executive Officer | |
| ECOLUTIONS GMBH & CO. KGAA | Alternative Power Generation | Director/Board Member | |
| Waterland Private Equity GmbH | Investment Managers | President | |
United Nations High Commissioner for Refugees
 United Nations High Commissioner for Refugees Services to the Health IndustryHealth Services The United Nations High Commissioner for Refugees, also known as UNHCR, is an organization that is committed to protecting the rights of refugees, forcibly displaced communities, and stateless individuals. The non-profit company is based in Suisse, Switzerland. The Swiss company's mission is to save lives and provide assistance to those who have been forced to flee their homes due to conflict, persecution, or other forms of violence. | Services to the Health Industry | Corporate Officer/Principal | |
| Université Catholique de Louvain | College/University | Doctorate Degree | |
Covagen AG
 Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Director/Board Member Founder | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Complix NV
 Complix NV Pharmaceuticals: MajorHealth Technology Complix NVengages in the development of biopharmaceutical company developing Alphabodies, a pipeline of transformative protein therapeutics. The Company is currently focusing its internal research and development activities on oncology and autoimmune diseases. Its therapeutic Alphabodies focuses on the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis and multiple sclerosis, and infectious diseases, and viral diseases such as influenza, HIV, and RSV. The company was founded by Mark Vaeck and Ignace Lasters in 2008 and is headquartered in Diepenbeek, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| Rhone-Poulenc Group | Public Communications Contact | ||
Fondation Ophtalmologique Adolphe de Rothschild
 Fondation Ophtalmologique Adolphe de Rothschild Hospital/Nursing ManagementHealth Services Fondation Ophtalmologique Adolphe de Rothschild is a specialized hospital in Paris, FR that focuses on treating all pathologies related to the head and neck for both adults and children. The hospital has a pharmacy that ensures the supply of medicines and medical devices. The hospital also has a clinical research service that serves as a one-stop-shop for investigators and industrial or academic partners. The hospital is supported by the Edmond de Rothschild Foundations, which offer a Medical Fellowship program to support talented and promising young practitioners in their hospital-university dynamic. The CEO of the French company is Julien Gottsmann. | Hospital/Nursing Management | Director/Board Member | |
| OBSEVA SA | Pharmaceuticals: Major | Founder | |
GamaMabs Pharma SA
 GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member | |
| Stanford Graduate School of Business | College/University | Graduate Degree | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
HealthCap Advisor AB
 HealthCap Advisor AB Investment ManagersFinance HealthCap Advisor AB provides investment advice. The private company is based in Stockholm, Sweden. | Investment Managers | Director/Board Member Corporate Officer/Principal | |
Inotrem SA
 Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Neuropore Therapies, Inc.
 Neuropore Therapies, Inc. Medical/Nursing ServicesHealth Services Neuropore Therapies, Inc. provides biopharmaceutical services. It also offers alpha-synuclein (ASYN), amyloid beta, autophagy, and publications programs. The company was founded by Eliezer Masliah in 2008 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
Ava AG
 Ava AG Miscellaneous Commercial ServicesCommercial Services Ava AG develops and offers a fertility band that allows for birth control. It offers a bracelet that indicates days on which it is possible to become pregnant. The company was founded by Lea von Bidder, Peter Stein, Philipp Tholen and Pascal Koenig in 2014 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
coparion Komplementär GmbH
 coparion Komplementär GmbH Investment ManagersFinance coparion Komplementär GmbH (coparion) is an independent venture capital firm founded in 2015. The firm is headquartered in Cologne, Germany, with another German office located in Cologne. | Investment Managers | Director/Board Member | |
| Creabilis SA | Director/Board Member Director/Board Member | ||
Neodigital Versicherung AG
 Neodigital Versicherung AG Life/Health InsuranceFinance Neodigital Versicherung AG is a holding company, which provides online insurance solutions. It offers accident insurance, home insurance, personal liability insurance, as well as pet owner liability insurance. The company was founded by Dirk Wittling and Stephen Voss on December 27, 2016 and is headquartered in Neunkirchen, Germany. | Life/Health Insurance | Director/Board Member | |
| Innociné Performance | Director/Board Member | ||
| MODALIS THERAPEUTICS CORPORATION | Biotechnology | Director/Board Member | |
Draupnir Bio ApS
 Draupnir Bio ApS Pharmaceuticals: MajorHealth Technology Draupnir Bio ApS engages in the manufacture and distribution of biotechnological and pharmaceutical products. It also provides medical research services. The company was founded on April 4, 2017 and is headquartered in Risskov, Denmark. | Pharmaceuticals: Major | Chairman Chief Operating Officer | |
| LUMOS PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 10 |
| Francia | 10 |
| Svizzera | 10 |
| Svezia | 7 |
| Germania | 7 |
Settori
| Health Technology | 24 |
| Finance | 10 |
| Consumer Services | 6 |
| Health Services | 5 |
| Commercial Services | 4 |
Posizioni
| Director/Board Member | 246 |
| Corporate Officer/Principal | 82 |
| Chairman | 52 |
| Independent Dir/Board Member | 44 |
| Chief Executive Officer | 32 |
Contatti più connessi
| Insiders | |
|---|---|
| Björn Ingemar Odlander | 53 |
| Stéphane Verdood | 32 |
| Elmar Schnee | 31 |
| Catherine Moukheibir | 29 |
| Renée Aguiar-Lucander | 26 |
| Claudio Nessi | 25 |
| Emmanuelle Coutanceau | 21 |
| Jesús Martin-Garcia | 20 |
| Robert Schier | 20 |
| Joseph McCracken | 20 |
| Gilles Nobécourt | 19 |
| Graham Dixon | 18 |
| Mary C. Tanner | 17 |
| Thomas Taapken | 16 |
| Milla Maria Koistinaho | 14 |
- Borsa valori
- Insiders
- Elias Papatheodorou
- Connessioni Società
